About Nippon India Nifty Pharma ETF
Nippon India Nifty Pharma ETF is a exchange traded fund (etf) managed by Nippon India Mutual Fund. Exchange Traded Funds track an index or a commodity such as gold or silver and are bought and sold on the stock exchange like shares.
The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.
Tax on your gains
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Work out what you would owe with the capital gains tax calculator.
Every plan and option, with scheme codes
| Plan | Option | NAV | Scheme code |
|---|---|---|---|
| Direct | Growth | ₹27.4664 | 149008 |
Frequently asked questions
What is the NAV of Nippon India Nifty Pharma ETF today?
The NAV of Nippon India Nifty Pharma ETF (Direct plan, Growth) is ₹27.4664, as of 18 Sept 2026.
What returns has Nippon India Nifty Pharma ETF given?
Over the last year the Direct plan returned 18.74%, and 20.37% a year over 3 years and 13.78% a year over 5 years. That places it 6 of 31 funds in its category over 3 years. Past returns do not guarantee future returns.
How much has Nippon India Nifty Pharma ETF fallen in the past?
Its deepest fall was 21% from 4 Oct 2021 to 13 Mar 2023. Of every one-year stretch in its history, 73% ended in a gain.
Which category does Nippon India Nifty Pharma ETF belong to?
It is a Exchange Traded Fund (ETF) from Nippon India Mutual Fund. Exchange Traded Funds track an index or a commodity such as gold or silver and are bought and sold on the stock exchange like shares.
How are gains from Nippon India Nifty Pharma ETF taxed?
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.